Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport
- PMID: 17072095
- DOI: 10.2133/dmpk.21.414
Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport
Abstract
The aim of this work is to develop a highly sensitive assay system for P-gp-mediated transport by using two methods, induction of P-gp and short-term culture of Caco-2 cells. To induce P-gp in Caco-2 cells, cells were cultured in vinblastine-containing medium. The mRNA level of P-gp was approximately 7-fold higher in Caco-2 cells cultured with vinblastine (P-gp-induced Caco-2 cells) than in control cells. Western blot analysis showed a significant increase in P-gp expression. After cell differentiation, the mRNA level of P-gp was downregulated, however, P-gp-induced Caco-2 cells still possessed a 5.6-fold higher mRNA level of P-gp compared to control cells. Polarized transport of substrate drugs was greater in the monolayer of P-gp-induced cells than in that of control cells. Moreover, we found that P-gp expression in Caco-2 cells could be further enhanced by applying the higher concentration of vinblastine. Transport activity of P-gp in Caco-2 cells cultured with higher concentration of vinblastine was markedly higher than that in P-gp-induced Caco-2 cells and was comparable with that in MDR1-MDCKII cells. In conclusion, this study provided a stable and highly sensitive in vitro assay system that can identify compounds that are subject to P-gp-mediated efflux.
Similar articles
-
Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines.Pharm Res. 2003 Aug;20(8):1119-24. doi: 10.1023/a:1025076326061. Pharm Res. 2003. PMID: 12948007
-
Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.Curr Drug Metab. 2007 May;8(4):325-40. doi: 10.2174/138920007780655450. Curr Drug Metab. 2007. PMID: 17504222
-
Model analysis of the concentration-dependent permeability of P-gp substrates.Pharm Res. 2010 Mar;27(3):442-6. doi: 10.1007/s11095-009-0026-9. Epub 2010 Feb 5. Pharm Res. 2010. PMID: 20135207
-
Psychotropic drug-drug interactions involving P-glycoprotein.CNS Drugs. 2012 Nov;26(11):959-73. doi: 10.1007/s40263-012-0008-z. CNS Drugs. 2012. PMID: 23023659 Review.
-
MDR- and CYP3A4-mediated drug-drug interactions.J Neuroimmune Pharmacol. 2006 Sep;1(3):323-39. doi: 10.1007/s11481-006-9034-2. Epub 2006 Aug 2. J Neuroimmune Pharmacol. 2006. PMID: 18040809 Review.
Cited by
-
Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide.Pharm Res. 2010 Oct;27(10):2141-9. doi: 10.1007/s11095-010-0216-5. Epub 2010 Aug 5. Pharm Res. 2010. PMID: 20686826
-
Rifampicin Induces Gene, Protein, and Activity of P-Glycoprotein (ABCB1) in Human Precision-Cut Intestinal Slices.Front Pharmacol. 2021 Jun 9;12:684156. doi: 10.3389/fphar.2021.684156. eCollection 2021. Front Pharmacol. 2021. PMID: 34177592 Free PMC article.
-
Efficient Generation of Small Intestinal Epithelial-like Cells from Human iPSCs for Drug Absorption and Metabolism Studies.Stem Cell Reports. 2018 Dec 11;11(6):1539-1550. doi: 10.1016/j.stemcr.2018.10.019. Epub 2018 Nov 21. Stem Cell Reports. 2018. PMID: 30472010 Free PMC article.
-
An in vitro human mammary epithelial cell permeability assay to assess drug secretion into breast milk.Int J Pharm X. 2022 Jun 22;4:100122. doi: 10.1016/j.ijpx.2022.100122. eCollection 2022 Dec. Int J Pharm X. 2022. PMID: 35789754 Free PMC article.
-
Intestinal oxidative state can alter nutrient and drug bioavailability.Oxid Med Cell Longev. 2009 Nov-Dec;2(5):322-7. doi: 10.4161/oxim.2.5.9769. Oxid Med Cell Longev. 2009. PMID: 20716920 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous